Brinker Capital Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.89M | Sell |
11,853
-9
| -0.1% | -$3.99K | 0.05% | 344 |
|
|
2026
Q1 | $5.3M | Sell |
11,862
-289
| -2% | -$135K | 0.05% | 347 |
|
|
2025
Q4 | $5.51M | Buy |
12,151
+1,803
| +17% | +$777K | 0.04% | 399 |
|
|
2025
Q3 | $4.05M | Sell |
10,348
-993
| -9% | -$415K | 0.03% | 504 |
|
|
2025
Q2 | $5.05M | Buy |
11,341
+1,768
| +18% | +$815K | 0.04% | 387 |
|
|
2025
Q1 | $4.64M | Buy |
9,573
+610
| +7% | +$284K | 0.05% | 367 |
|
|
2024
Q4 | $3.61M | Buy |
8,963
+154
| +2% | +$71.4K | 0.04% | 428 |
|
|
2024
Q3 | $4.1M | Sell |
8,809
-710
| -7% | -$341K | 0.04% | 399 |
|
|
2024
Q2 | $4.46M | Buy |
9,519
+1,133
| +14% | +$492K | 0.05% | 343 |
|
|
2024
Q1 | $3.51M | Sell |
8,386
-1,623
| -16% | -$686K | 0.04% | 425 |
|
|
2023
Q4 | $4.19M | Sell |
10,009
-485
| -5% | -$179K | 0.05% | 344 |
|
|
2023
Q3 | $3.65M | Sell |
10,494
-1,048
| -9% | -$367K | 0.04% | 379 |
|
|
2023
Q2 | $4.06M | Buy |
11,542
+662
| +6% | +$223K | 0.04% | 374 |
|
|
2023
Q1 | $3.43M | Buy |
10,880
+2,955
| +37% | +$886K | 0.04% | 373 |
|
|
2022
Q4 | $2.29M | Sell |
7,925
-1,258
| -14% | -$383K | 0.05% | 420 |
|
|
2022
Q3 | $2.66M | Sell |
9,183
-480
| -5% | -$138K | 0.06% | 350 |
|
|
2022
Q2 | $2.72M | Sell |
9,663
-3,718
| -28% | -$995K | 0.05% | 356 |
|
|
2022
Q1 | $3.49M | Sell |
13,381
-43
| -0.3% | -$10.2K | 0.05% | 336 |
|
|
2021
Q4 | $2.95M | Buy |
13,424
+2,301
| +21% | +$447K | 0.04% | 426 |
|
|
2021
Q3 | $2.24M | Hold |
11,123
| – | – | 0.04% | 521 |
|
|
2021
Q2 | $2.24M | Buy |
11,123
+36
| +0.3% | +$7.53K | 0.03% | 574 |
|
|
2021
Q1 | $2.38M | Sell |
11,087
-11,596
| -51% | -$2.55M | 0.04% | 458 |
|
|
2020
Q4 | $5.36M | Buy |
22,683
+12,838
| +130% | +$2.95M | 0.08% | 285 |
|
|
2020
Q3 | $2.68M | Buy |
+9,845
| New | +$2.72M | 0.05% | 382 |
|
|
2020
Q1 | – | Sell |
-72
| Closed | -$16K | – | 750 |
|
|
2019
Q4 | $16K | Buy |
72
+5
| +7% | +$1.01K | ﹤0.01% | 528 |
|
|
2019
Q3 | $11K | Sell |
67
-436
| -87% | -$77.1K | ﹤0.01% | 569 |
|
|
2019
Q2 | $92K | Buy |
503
+229
| +84% | +$40K | ﹤0.01% | 498 |
|
|
2019
Q1 | $50K | Buy |
+274
| New | +$50.6K | ﹤0.01% | 475 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | – | – | 652 |
|
|
2016
Q3 | $0 | Buy |
+3
| New | +$284 | ﹤0.01% | 629 |
|
|
2016
Q1 | – | Sell |
-12
| Closed | -$2K | – | 690 |
|
|
2015
Q4 | $2K | Buy |
12
+3
| +33% | +$362 | ﹤0.01% | 475 |
|
|
2015
Q3 | $1K | Buy |
+9
| New | +$1.16K | ﹤0.01% | 442 |
|
Other funds holding VRTX
Brinker Capital Investments's VRTX Position: Q2 2026 in Review
Brinker Capital Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 0.08% in Q2 2026, selling an estimated $3.99K and leaving 11,853 shares worth $5.89M. The position accounts for 0.05% of the portfolio, ranked #344.
Brinker Capital Investments first reported a position in VRTX in Q3 2015 and has held it in 31 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Brinker Capital Investments held 11,853 shares of Vertex Pharmaceuticals worth $5.89M as of Q2 2026.
- Brinker Capital Investments sold 9 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.99K.
- Vertex Pharmaceuticals made up 0.05% of Brinker Capital Investments's portfolio in Q2 2026, its #344 holding.
- Brinker Capital Investments first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 31 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.